Flu vaccine ineffective for people 65 and older last winter

June 21, 2017 by Mike Stobbe
In this Friday, Sept. 16, 2016 file photo, a woman receives a flu vaccine shot at a community fair in Brownsville, Texas. On Wednesday, June 21, 2017, U.S. health officials released new estimates showing the previous winter's flu vaccine was ineffective in protecting older Americans against the illness, even though the vaccine was well-matched to the flu bugs going around. (Jason Hoekema/The Brownsville Herald via AP)

The flu vaccine did a poor job protecting older Americans against the illness last winter, even though the vaccine was well-matched to the flu bugs going around.

U.S. health officials on Wednesday released new vaccine data showing it did a so-so job overall.

The vaccine was about 42 percent effective in preventing illness severe enough to send a patient to the doctor's office. But it was essentially ineffective protecting some age groups. That includes people 65 and older—the group that's hardest hit by flu, suffering the most deaths and hospitalizations.

The flu season that just ended was a long one that peaked in February and was considered moderately severe. But the flu-related hospitalization rate for older adults was the highest it's been since the severe 2014-2015 flu season.

Like that season, last winter was dominated by a kind of flu—Type A H3N2—that tends to cause more deaths and serious illnesses than other seasonal flu viruses.

In three of the last seven flu seasons, flu vaccine was essentially ineffective in seniors, according to past studies. The worst performances tend to be in H3N2-dominant seasons.

Health officials say flu vaccine still protects many people. And even if fares poorly against the dominant virus, it can do a good job against other circulating flu strains.

"While it is clear we need better flu vaccines, it's important that we not lose sight of the important benefits of vaccination with currently available vaccines," said Jill Ferdinands, a flu epidemiologist at the Centers for Disease Control and Prevention, in a statement.

The CDC calculates vaccine effectiveness from a sample of flu tests done on patients in five states.

Vaccines against some other infectious diseases are not considered successful unless they are at least 90 percent effective. But flu is particularly challenging. Over the last ten winters, overall flu vaccine effectiveness has averaged about 46 percent.

Last winter's vaccine did well in protecting young children, about 60 percent effective. And it did OK in older children and in adults ages 50 to 64. But it had no clear effect in adults 18 to 49, or among the oldest adults.

Results were presented at a meeting in Atlanta of the Advisory Committee on Immunization Practices, which provides vaccine advice to the CDC.

CDC officials said the numbers are preliminary. Investigators are trying to figure out whether past flu vaccinations made a difference in how well the most recent flu shot worked, and whether there's a way to check more people to see how quickly the vaccine's protection is lasting.

Experts also are looking at whether certain brands of vaccine offer more protection than others. About 40 percent of older Americans get a higher-dose flu vaccine that is supposed to work better.

Flu shots are recommended for virtually all Americans age 6 months or older.

Among infectious diseases, flu is considered one of the U.S.'s leading killers. CDC estimates there are tens of thousands of deaths each year from flu and pneumonia.

Explore further: In a bad flu season, high-dose flu vaccine appeared better at preventing deaths in seniors

Related Stories

In a bad flu season, high-dose flu vaccine appeared better at preventing deaths in seniors

March 2, 2017
The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare ...

US flu vaccine a good match; season moderate so far

February 16, 2017
This season's flu vaccine seems to be working pretty well, weakening the punch of a nasty bug that's going around, U.S. health officials said Thursday.

Flu vaccine more effective this year; milder season so far

February 24, 2016
The flu vaccine is doing a better job this year.

Shingles vaccine cuts chronic pain, hospitalizations

March 17, 2017
(HealthDay)—Vaccination greatly reduces the risk of serious complications from shingles, a new study finds.

Flu shot did poor job against worst bug in seniors

February 21, 2013
Health officials say this season's flu shot is only 9 percent effective in protecting seniors against the most common and dangerous flu bug.

This year's flu vaccine guards against new strains

September 27, 2012
(AP)—Time to get your flu vaccine. And remember: Last year's shot won't protect you this year.

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.